<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05069571</url>
  </required_header>
  <id_info>
    <org_study_id>EA-21-009</org_study_id>
    <nct_id>NCT05069571</nct_id>
  </id_info>
  <brief_title>Endoangel Withdrawal Overspeed Analysis</brief_title>
  <official_title>Explore the Relationship Between the Percentage of Overspeed of Colonoscopy Withdrawal and the Rate of Adenoma Detection:a Prospective、Multicenter、Observational Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Renmin Hospital of Wuhan University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Renmin Hospital of Wuhan University</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Exploring the relationship between the percentage of overspeed of colonoscopy withdrawal and&#xD;
      the rate of adenoma detection.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">March 1, 2020</start_date>
  <completion_date type="Anticipated">February 1, 2022</completion_date>
  <primary_completion_date type="Anticipated">November 1, 2021</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Crossover</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Adenoma detection rate</measure>
    <time_frame>3 months</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Proportion of withdrawal overspeed</measure>
    <time_frame>3 months</time_frame>
  </secondary_outcome>
  <enrollment type="Anticipated">1210</enrollment>
  <condition>Colorectal Neoplasms</condition>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Endoangel</intervention_name>
    <description>Collecting the colonoscopy videos and analyzing the correlation between withdrawal overspeed proportion and adenoma detection rate.</description>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patients need to receive the colonoscopy examination.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          1. Males or females who are over 18 years old (inclusive);&#xD;
&#xD;
          2. Enteroscopy and related examinations are needed to further clarify the characteristics&#xD;
             of digestive tract diseases;&#xD;
&#xD;
          3. Able to read, understand and sign the informed consent form;&#xD;
&#xD;
          4. The researcher believes that the subject can understand the process of the clinical&#xD;
             research, is willing and able to complete all the research procedures and follow-up&#xD;
             visits, and cooperate with the research procedures.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          1. Participated in other clinical trials, signed an informed consent form and within the&#xD;
             follow-up period of other clinical trials;&#xD;
&#xD;
          2. Abuse of drugs or alcohol or mental disorders in the last 5 years;&#xD;
&#xD;
          3. Women during pregnancy or breastfeeding;&#xD;
&#xD;
          4. Subjects with previous history of bowel surgery;&#xD;
&#xD;
          5. The investigator believes that the subject is not suitable for enteroscopy and related&#xD;
             examinations;&#xD;
&#xD;
          6. The investigator believes that the subject is not suitable for high-risk diseases or&#xD;
             other special circumstances to participate in clinical trials.&#xD;
&#xD;
          7. Patients with gastrointestinal bleeding;&#xD;
&#xD;
          8. Known or highly suspected allergy to any ingredient of bowel cleansing agent;&#xD;
&#xD;
          9. Restricted activities or any mental or physical condition impairs their ability to&#xD;
             drink intestinal cleansing preparations;&#xD;
&#xD;
         10. Known or suspected intestinal obstruction or perforation, toxic megacolon, most&#xD;
             colectomy, heart failure (grade III or IV), severe cardiovascular disease, severe&#xD;
             liver failure or end, renal insufficiency, etc.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Honggang Yu, Doctor</last_name>
    <phone>13871281899</phone>
    <email>yuhonggang@whu.edu.cn</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Liwen Yao, Doctor</last_name>
    <phone>15827416837</phone>
    <email>292779656@qq.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Renmin Hospital of Wuhan University</name>
      <address>
        <city>Wuhan</city>
        <state>Hubei</state>
        <zip>430060</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Honggang Yu, Doctor</last_name>
    </contact>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>September 2021</verification_date>
  <study_first_submitted>September 24, 2021</study_first_submitted>
  <study_first_submitted_qc>September 24, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">October 6, 2021</study_first_posted>
  <last_update_submitted>September 24, 2021</last_update_submitted>
  <last_update_submitted_qc>September 24, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">October 6, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Colorectal Neoplasms</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

